I-Flow/HAPC
This article was originally published in The Gray Sheet
Executive Summary
Proposed sale price of I-Flow's InfuSystem infusion pump distribution subsidiary is reduced from $140 million to $100 million, plus a $12 million "earn out payment," under a memorandum of intent with purchaser HAPC, the firms announce Sept. 12. The price cut "reflects the realities of today's economic environment and the marketplace," explains I-Flow CEO Donald Earhart. The planned divestiture was announced last September to allow I-Flow to focus on its On-Q pain drug-delivery devices (1"The Gray Sheet" Oct. 9, 2006, p. 11)